MicroRNA-7 Inhibits Rotavirus Replication by Targeting Viral NSP5 In Vivo and In Vitro

Yan Zhou1, Linlin Chen1, Jing Du1

  • 1Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on severe Infectious Disease, Kunming 650118, China.

Viruses
|February 20, 2020
PubMed

Insights

MicroRNAs (miRNAs) show antiviral potential against rotavirus (RV). This study found that miR-7 inhibits RV replication by targeting the RV NSP5 protein, offering a potential new therapeutic strategy.

Area of Science:

  • Virology
  • Molecular Biology
  • Microbiology

Background:

  • Rotavirus (RV) is a primary cause of severe diarrhea in young children.
  • Current treatments for rotavirus are limited to supportive care and preventive vaccines.
  • MicroRNAs (miRNAs) are increasingly recognized for their role in regulating viral infections.

Purpose of the Study:

  • To investigate the antiviral effects of miRNAs during rotavirus replication.
  • To determine if miR-7 plays a role in controlling rotavirus infection.

Main Methods:

  • Quantifying miR-7 expression in rotavirus-infected cells.
  • Identifying the target of miR-7 within the rotavirus replication cycle.
  • Assessing the impact of miR-7 on viroplasm formation and viral replication.
  • Evaluating the efficacy of miR-7 in a mouse model of rotavirus diarrhea.

Main Results:

  • miR-7 expression was upregulated during rotavirus replication.
  • miR-7 directly targets the rotavirus NSP5 protein.
  • miR-7 inhibited rotavirus replication by downregulating NSP5 expression and affecting viroplasm formation.
  • miR-7 demonstrated antiviral activity both in vitro and in vivo.

Conclusions:

  • Upregulation of miR-7 is a host response to rotavirus infection across different G-types.
  • miR-7 exhibits significant antiviral properties against rotavirus.
  • Cellular miR-7 represents a potential target for novel small RNA-based anti-rotavirus therapeutics.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.6K